VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Shane Stokes
December 14, 2017
Chris Froome urine test reveals twice the legal amount of Salbutamol; Nibali on Froome salbutamol case: No one can give me back the thrill of winning the Vuelta; Vuelta a España expresses ‘extreme caution’ about Froome situation; The Secret Pro: My thoughts on Froome’s positive and the bikes we ride; Tucker analyses Froome case; INRNG on what comes next for Froome; Podcast: Chris Froome’s positive; Ewan confirmed for Tour de France debut in 2018; Stig Broeckx pushes through rehab; Aqua Blue reveals 2018 kit
Chris Froome (Team Sky) has returned an “adverse analytical finding” for Salbutamol in a urine sample taken at this year’s Vuelta a Espana. The sample, which was taken after stage 18 of the Vuelta — a race Froome went on to win — contained 2,000 nanograms per millilitre (ng/ml) of Salbutamol, twice the 1,000 ng/ml permitted by the World Anti Doping Agency (WADA).
An analysis of Froome’s B sample confirmed the results of the A sample and, according to the UCI, “proceedings are being conducted in line with the UCI Anti-Doping Rules”.
Salbutamol is a common medication used to relieve the symptoms of asthma and is permitted for use without a therapeutic use exemption, up to a threshold. Froome reportedly experienced “acute asthma symptoms” during the Vuelta a Espana, requiring further medication.
“It is well known that I have asthma and I know exactly what the rules are,” Froome said via a Team Sky press release. “I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader’s jersey.
“My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my Salbutamol dosage. As always, I took the greatest care to ensure that I did not use more than the permissible dose.”
Click through to read the full story on CyclingTips.